Drug intelligence / Profile preview

Chaihu Anxin Capsule

Development stage
Unknown
Lead developer
The First Hospital of Hebei Medical University
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Chaihu Anxin Capsule is a Traditional Chinese Medicine (TCM) botanical formulation developed by The First Hospital of Hebei Medical University for the treatment of mild to moderate depressive disorder. It is currently undergoing clinical evaluation in China to determine its efficacy and safety in patients experiencing a single episode of depression. The therapeutic approach involves investigating the drug's impact on the gut microbiome, suggesting a mechanism of action involving the gut-brain axis. The name 'Chaihu' refers to *Bupleurum*, a staple herb in TCM used for its purported ability to relieve emotional stagnation and regulate the liver-qi, which is traditionally linked to mood regulation.

Brand names
Chaihu Anxin Capsule
Other names
Chaihu Anxin Capsule
02

Targets

JUN (Transcription factor Jun)STAT3 (Signal Transducer and Activator of Transcription 3)AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)TP53 (Cellular Tumor Antigen p53 R175H)IL-6 (Interleukin 6)

Beyond the preview

Go deeper on Chaihu Anxin Capsule.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chaihu Anxin Capsule.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call